Alpelisib
規格
1217486-61-7CAS番号
806-598-7EC番号
(2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4-pyridinyl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamideIUPAC名
C19H22F3N5O2S化学式
441.5 g/mol分子量
alpelisib; 1217486-61-7; BYL-719; BYL719; Piqray; NVP-BYL719; Vijoice; BYL 719; 08W5N2C97Q; (2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide; 1,2-Pyrrolidinedicarboxamide, N1-(4-methyl-5-(2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl)-2-thiazolyl)-, (2S)-; 1,2-PYRROLIDINEDICARBOXAMIDE, N1-[4-METHYL-5-[2-(2,2,2-TRIFLUORO-1,1-DIMETHYLETHYL)-4-PYRIDINYL]-2-THIAZOLYL]-, (2S)-; DTXSID70153355; (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-(4-methyl-5-(2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl)thiazol-2-yl)amide; alpelisibum; (2S)-1-N-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)-1,3-thiazol-2-yl)pyrrolidine-1,2-dicarboxamide; (2S)-1-N-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide; (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl]thiazol-2-yl]amide; RefChem:57062; DTXCID7075846; L01XX65; Phosphoinositide 3-kinase Inhibitor BYL719; Alpelisib (BYL719); (S)-N1-(4-Methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxamide; UNII-08W5N2C97Q; (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide; Alpelisib [USAN:INN]; MFCD22417085; CHEMBL2396661; (2s)-N~1~-{4-Methyl-5-[2-(1,1,1-Trifluoro-2-Methylpropan-2-Yl)pyridin-4-Yl]-1,3-Thiazol-2-Yl}pyrrolidine-1,2-Dicarboxamide; (S)-N1-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxamide.; Alpelisib [INN]; C19H22F3N5O2S; A lpelisib; 4jps; 1LT; Alpelisib [USAN]; Vijoice (TN); Piqray (TN); ALPELISIB [JAN]; ALPELISIB [MI]; ALPELISIB [WHO-DD]; Alpelisib (JAN/USAN/INN); GTPL7955; orb1226776; orb1307105; SCHEMBL1911869; ALPELISIB [ORANGE BOOK]; SCHEMBL29358059; CHEBI:93752; EX-A405; STUWGJZDJHPWGZ-LBPRGKRZSA-N; BDBM738244; BYL 719; BYL719; GLXC-90284; BDBM50436459; EBC-11472; NSC765974; NSC800065; s2814; AKOS022186315; CCG-269139; CS-0663; DB12015; FP71607; NSC-765974; NSC-800065; SDCCGSBI-0654479.P001; US20250145589, Example Alpelisib; NCGC00346717-03; NCGC00346717-06; NCGC00346717-09; NCGC00346717-12; (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidine; (2S)-N1-{4-METHYL-5-[2-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)PYRIDIN-4-YL]-1,3-THIAZOL-2-YL}PYRROLIDINE-1,2-DICARBOXAMIDE; AC-37083; AS-16349; HY-15244; B9700; NS00072895; SW220128-1; cas:1217486-61-7;BYL-719; D11011; EN300-23810842; BRD-K54997624-001-06-0; Q27074391; (2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4-pyridinyl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide; (2S)-N1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-4-pyridyl]thiazol-2-yl]pyrrolidine-1,2-dicarboxamide; (2S)-N1-{4-Methyl-5-[1-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide; BYL-719A-1214(S)-N1-(4-METHYL-5-(2-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)PYRIDIN-4-YL)THIAZOL-2-YL)PYRROLIDINE-1,2-DICARBOXAMIDE別名
Alpelisibを含む製品
피크레이정50밀리그램(알펠리십), 피크레이정150밀리그램(알펠리십), 피크레이정200밀리그램(알펠리십)PIQRAY 50 MG y 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPIQRAY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPIQRAY 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPIQRAY 50 mg et 200 mg, comprimé pelliculéPIQRAY 200 mg, comprimé pelliculéPIQRAY 150 mg, comprimé pelliculéAlpelisib - ArevipharmaAlpelisib - Novartis Pharmaceuticals CorporationAlpelisibAlpelisibAlpelisib
